Axsome Therapeutics
Price & Volume
Stats
See moreOpen | $148.86 |
Previous Close | $149.44 |
Day Range | $148.03-$150.48 |
52W Range | $75.56-$149.76 |
Market Cap | $7.5B |
Shares Short | 3M |
Financials
See moreRevenue (12 Mos) | $561.2M |
Revenue Growth (YoY) | 63.2% |
Gross Profit (12 Mos) | $515.6M |
Diluted EPS | -$4.68 |
News
See moreYahoo Finance • 18 days ago
Axsome Therapeutics Acquires Subtype Selective GABA-A Receptor Positive Allosteric Modulator AZD7325 for the Treatment of Epilepsy
Yahoo Finance • 18 days ago
Avenue Therapeutics Announces Acquisition of Subsidiary Baergic Bio by Axsome Therapeutics
Yahoo Finance • 22 days ago
Here are the major earnings before the open Monday
Yahoo Finance • 2 months ago
Axsome Therapeutics to Report Third Quarter 2025 Financial Results on November 3
About
CEO | Dr. Herriot Tabuteau M.D. |
Address | One World Trade Center, New York, NY, United States, 10007 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 816 |
